Peter Wehrwein

Vertical integration of health care draws regulatory scrutiny.

The proportion of cancer patients who are 50-64 is increasing while the proportion of those 65 and older is shrinking.

Experts expect more lawsuits challenging CMS’s authority to negotiate drug prices for Medicare Part D.

While a specialist can help people who are already ill, primary care doctors can help people from becoming ill.

Larger payers will look for “adjacencies” rather than merger and acquisition with other payers because of the regulatory environment.